Tandem Diabetes Care®, Inc Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems
July 30, 2015Tandem Diabetes Care announced that it has entered into non-exclusive Development Agreements with Dexcom, Inc. to allow the integration of future generation Tandem insulin pumps with the Dexcom G5 and G6 continuous glucose monitoring systems.
More »
Otonomy Initiates Phase 2 Clinical Trial for AuriPro(TM) in Second Label Expansion Indication
July 28, 2015Otonomy enrolls the first patients in a Phase 2 clinical trial evaluating AuriPro for the treatment of swimmer's ear. The study will evaluate the feasibility of administering AuriPro to the ear canal in a physician's office setting.
More »
Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension
July 28, 2015Esperion announces positive top-line results and primary endpoint from its Phase 2 study evaluating the safety and efficacy of LDL-Cholesterol lowering ETC-1002 in patients with hypercholesterolemia and hypertension.
More »